Next |
home / stock / bgne / bgne message board
Subject | By | Source | When |
---|---|---|---|
BGNE having a nice bounce and a good, | MiamiGent | investorshub | 07/05/2023 7:28:03 PM |
Thoughts on where this is headed? | StockLearner2011 | investorshub | 07/03/2023 9:49:33 PM |
Found an interesting article | luke424 | investorshub | 06/30/2023 1:45:08 AM |
$BGNE must see | StockLearner2011 | investorshub | 06/28/2023 1:49:55 AM |
here we go bulls news is here | StockLearner2011 | investorshub | 06/22/2023 3:12:55 PM |
Have a look at this | StockLearner2011 | investorshub | 06/22/2023 12:11:10 PM |
$BGNE MomentumIts trading | north40000 | investorshub | 06/21/2023 3:35:51 AM |
The trading last up | StockLearner2011 | investorshub | 06/20/2023 3:13:09 PM |
$BGNE short squeeze | luke424 | investorshub | 06/18/2023 5:16:26 AM |
MomentumIts now up | SweepsMcGee | investorshub | 06/14/2023 10:32:03 AM |
$BGNE where is the squeeze? | StockLearner2011 | investorshub | 06/12/2023 12:02:18 AM |
$BGNE should we be shorting? | StockLearner2011 | investorshub | 04/30/2023 7:59:54 PM |
$BGNE The trading | north40000 | investorshub | 04/29/2023 7:28:01 PM |
Long and strong lets hope im right | luke424 | investorshub | 04/27/2023 12:28:02 AM |
$BGNE short squeeze | MiamiGent | investorshub | 04/24/2023 3:35:51 PM |
Price gaining | StockLearner2011 | investorshub | 04/23/2023 2:43:18 PM |
Looks pretty positive | StockLearner2011 | investorshub | 04/17/2023 6:19:38 AM |
$BGNE MomentumIts now | StockLearner2011 | investorshub | 04/05/2023 2:19:08 AM |
$BGNE $271.915 +$6.91 (+2.609%) | MiamiGent | investorshub | 01/19/2023 2:49:53 PM |
BGNE presently $269.42 +$6.19 (+2.35%) | MiamiGent | investorshub | 01/13/2023 7:42:57 PM |
News, Short Squeeze, Breakout and More Instantly...
BeiGene Ltd. Company Name:
BGNE Stock Symbol:
NASDAQ Market:
U.S. stock futures were higher this morning, with the Dow futures gaining by around 0.1% on Friday. Shares of Lululemon Athletica Inc. (NASDAQ: L...
On Thursday, the FDA approved BeiGene Ltd’s (NASDAQ:BGNE) approved Tevimbra (tislelizumab-jsgr) as monotherapy for adult patients w...
Results from the global, Phase 3 RATIONALE 302 trial showed TEVIMBRA prolonged the survival of patients who received prior systemic treatment compared to chemotherapy Approval represents the first indication in the U.S. for TEVIMBRA BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE:...